Health Care: Drugs

Clovis Oncology Inc (CLVS: NASDAQ)

$57.68 n/a | n/a%
12/18/14 - 04:00 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011
Sales 0.00 0.00 0.00
Cost of Sales 0.00 0.00 0.00
Gross Operating Profit 0.00 0.00 0.00
Selling, General, and Administrative Expenses 16.57M 10.64M 6.86M
Research & Development 66.54M 58.89M 40.73M
Operating Income before D & A (EBITDA) -83.11M -69.53M -47.59M
Depreciation & Amortization 250.00K 363.00K 326.00K
Interest Income 0.00 0.00 0.00
Other Income - Net -1.12M -228.00K -957.00K
Special Income / Charges -500.00K -8.50M -14.00M
Total Income Before Interest Expenses (EBIT) -84.73M -74.37M -55.87M
Interest Expense 0.00 0.00 0.00
Pre-Tax Income -84.73M -74.37M -55.87M
Income Taxes 52.00K -27.00K 27.00K
Minority Interest 0.00 0.00 0.00
Net Income From Continuing Operations -84.53M -73.98M -55.57M
Net Income From Discontinued Operations 0.00 0.00 0.00
Net Income From Total Operations -84.53M -73.98M -55.57M
Extraordinary Income/Losses 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00
Total Net Income -84.53M -73.98M -55.57M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-84.28M -69.73M -48.57M
Preferred Dividends
Net Income Available To Common -84.53M -73.98M -55.57M
Basic EPS from Continuing Ops. -2.95 -2.97 -14.42
Basic EPS from Discontinued Ops. 0.00 0.00 0.00
Basic EPS from Total Operations -2.95 -2.97 -14.42
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00
Basic EPS, Total -2.95 -2.97 -14.42
Basic Normalized Net Income/Share -2.94 -2.80 -12.60
EPS fr Continuing Ops. -2.95 -2.97 -14.42
EPS fr Discontinued Ops 0.00 0.00 0.00
EPS fr Total Ops. -2.95 -2.97 -14.42
EPS fr Extraord. Inc. 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00
EPS, Total -2.95 -2.97 -14.42
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-2.94 -2.80 -12.60
Dividends Paid per Share 0.00 0.00 0.00

Portfolios with CLVS

Latest CLVS Headlines from TheStreet

More Financial News for CLVS

Press Releases for CLVS

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter